The overactive bladder

Reviews in Contemporary Pharmacotherapy

Volumn 11, Issue 1, 2000, Pages 1-11

  Bulmer, Paul ^a   Abrams, Paul ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; TOLTERODINE;

ANTICHOLINERGIC EFFECT; BLADDER DYSFUNCTION; DENERVATION; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HUMAN; MALE; MORBIDITY; NOMENCLATURE; PATIENT COMPLIANCE; QUALITY OF LIFE; RECEPTOR AFFINITY; REVIEW; SALIVARY GLAND; SIDE EFFECT; SYMPTOM; URGE INCONTINENCE; URINE INCONTINENCE; URODYNAMICS;

EID: 0033973370     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Abrams PH. Bladder instability: concept, clinical associations and treatment. Scand J Urol Nephrol Suppl 1984; 87: 7-13.
2. Abrams P, Wein AJ. The overactive bladder and incontinence: definitions and a plea for discussion. Neurourol Urodyn 1999; 18: 413-416.
3. Abrams PH, Blaivas JG, Stanton SL, Andersen JT. Standardization of terminology of lower urinary tract function. Neurourol Urodyn 1988; 7: 403-427.
4. Andersson KE, Appell R, Cardozo L et al. Pharmacological treatment of urinary incontinence. In: Abrams P, Khoury S, Wein A. Incontinence. Proceedings of the First International Consultation on Incontinence. Monaco, 28 June-1 July, 1998. Plymouth: Health Publications, 1999: 447-487.
5. Appell RA. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Urology 1997; 50 (6A Suppl): 90-96.
6. Awad SA, Al-Zahrani HM, Gajewski JB, Bourque-Kehoe AA. Long term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 1998; 81: 569-573.
7. Blok BFM, Willemsen ATM, Holstege G. A PET study on the brain control of micturition in humans. Brain 1997; 20: 111-121.
8. Bolognese JA, Kozloff RC, Kunitz SC, Grino PB, Patrick DC, Stoner E. Validation of a symptoms questionnaire for benign prostatic hyperplasia. Prostate 1992; 21: 247-254.
9. Bosch R. Instability of the bladder: pathophysiology unknown? A synopsis of clinical points of interest. Neurourol Urodyn 1990; 9: 563-565.
10. Brendler CB, Radebaugh LC, Mohler JL. Topical oxybutynin chloride for relaxation of dysfunctional bladders. J Urol 1989; 141: 1350-1354.
11. Briggs K, Castledon CM, Asher MJ. The effect of flavoxate on inhibited detrusor contractions and urinary incontinence in the elderly. J Urol 1980; 123: 665-666.
12. Buyse G, Waldeck K, Verpoorten C, Bjork K, Casaer P, Andersson KE. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol 1998; 160: 892-896.
13. Byrne DJ, Hamilton Stewart PA, Gray BK. The role of urodynamics in female urinary stress incontinence. Br J Urol 1987; 59: 228-229.
14. Cardozo LD, Stanton SL, Hafner J, Allan V. Biofeedback in the treatment of detrusor instability. Br J Urol 1978; 50: 250-254.
15. Chapple C, Parkhouse H, Gardener C, Milroy FJG. Double-blind, placebo-controlled, crossover study of flavoxate in the treatment of idiopathic detrusor instability. Br J Urol 1990; 66: 491-494.
16. Dahm TC, Ostri P, Kristensen J et al. Flavoxate treatment in micturition disorders accompanying benign prostatic hypertrophy: a double-blind, placebo-controlled, multicenter investigation. Urol Int 1995; 55: 205-208.
17. de Groat WC. Nervous control of the urinary bladder of the cat. Brain Res 1975; 87: 201-214.
18. de Groat WC, Booth AM, Yoshimura N. Neurophysiology of micturition and its modification in animal models of human disease. In: Maggi CA, ed. The autonomic nervous system, vol 3, nervous control of the urogenital system. London: Harwood Academic Publishers, 1993: 222-290.
19. Donovan JL, Abrams P, Peters TJ et al. The ICS 'BPH' study: the psychometric validity and reliability of the ICS male questionnaire. Br J Urol 1996; 77: 554-562.
20. Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction 3. Detrusor overactivity. J Urol 1993a; 150: 1668-1680.
21. Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction 4. Bladder outlet obstruction. J Urol 1993b; 150: 1681-1695.
22. Elbadawi A, Hailemariam S, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction 7. Prospective ultrastructural/urodynamic evaluation of its natural evolution. J Urol 1997; 157: 1814-1822.
23. Elving LB, Foldspang A, Lam GW, Mommsen S. Descriptive epidemiology of urinary incontinence in 3,100 women age 30-59. Scand J Urol Nephrol Suppl 1989; 125: 37-43.
24. Eriksen BC, Bergmann S, Eik-Nes SH. Maximal electrical stimulation of the pelvic floor in female idiopathic detrusor instability and urge incontinence. Neurourol Urodyn 1989; 8: 219-230.
25. Fall M. Long term intravaginal electrical stimulation in urge and stress incontinence. Scand J Urol Nephrol Suppl 1978; 44: 55-58.
26. Freeman RM, Boxby K. Hypnotherapy for incontinence caused by detrusor instability. Br Med J 1982; 284: 1831-1832.
27. Frewen W. Rcle of bladder training in the treatment of the overactive bladder in the female. Urol Clin North Am 1979; 6: 273-279.
28. Hampel C, Wienhold D, Benken N, Eggersmann C, Thuroff JW. Definition of overactive bladder and epidemiology of urinary incontinence. Urology 1997; 50 (Suppl 6A): 4-14.
29. Herschorn S, Hewitt RJ. Patient perspective of long term outcome of augmentation cystoplasty for neurogenic bladder. Urology 1998; 52: 672-678.
30. Holmes DM, Stone AR, Barry PR, Richards CJ, Stephenson TP. Bladder training: 3 years on. Br J Urol 1983; 55: 660-664.
31. Ingleman-Sundberg A. Urge incontinence in women. Acta Obstet Gynaecol Scand 1975; 54: 153-156.
32. Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 1996; 77: 805-812.
33. Jarvis GJ, Hall S, Stamp S, Millar DR, Johnson A. An assessment of urodynamic investigation in incontinent women. Br J Obstet Gynaecol 1980; 87: 893-896.
34. Kelleher CJ, Cardozo LD. Sexual dysfunction and urinary incontinence. J Sex Health 1994; 3: 186-191.
35. Kwak TI, Lee JG. Inhibitory effects of propiverine, atropine and oxybutynin on bladder instability in rats with infravesical outlet obstruction. Br J Urol 1998; 82: 272-277.
36. Lagro-Janssen FM, Debruyne FMJ, Van Weel C. Value of the patient's case history in diagnosing urinary incontinence in general practice. Br J Urol 1991; 67: 569-572.
37. Larsson G, Abrams P, Victor A. The frequency volume chart in detrusor instability. Neurourol Urodyn 1991; 10: 533-543.
38. Mallory BS, Roppolo JR, de Groat WC. Pharmacological modulation of the pontine micturition centre. Brain Res 1991; 546: 310-320.
39. Malone-Lee JG. New data on urodynamics in the symptomatic elderly. Neurourol Urodyn 1988; 7: 119-222.
40. McInerney PD, Harris SA, Pritchard A, Stephenson TP. Night studies for primary diurnal and nocturnal eneuresis and preliminary results of the clam ileocystoplasty. Br J Urol 1991; 67: 42-43.
41. Nilvebrant L. The mechanism of action of tolterodine. Rev Contemp Pharmacother 2000; 11: 13-25.
42. Shaker HS, Hassouna M. Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence. J Urol 1998; 159: 1516-1519.
43. Shepherd AM, Powell PH, Ball AJ. The place of urodynamic studies in the investigation and treatment of female urinary tract symptoms. J Obstet Gynaecol 1982; 3: 123-125.
44. Sifo Research and Consulting AB. A multinational tracking survey on overactive bladder problems. Stockholm: Sifo Research and Consulting, 1998.
45. Swami KS, Feneley RCL, Hammonds JC, Abrams P. Detrusor myomectomy for detrusor overactivity. A minimum 1 year follow up. Br J Urol 1998; 81: 68-72.
46. Thomas DG. Clinical urodynamics in neurogenic bladder dysfunction. Urol Clin North Am 1979; 6: 237-253.
47. Torrens MJ, Griffiths HB. The control of the uninhibited bladder by selective sacral neurectomy. Br J Urol 1974; 46: 639-643.
48. Torrens MJ, Morrison JFB. The physiology of the lower urinary tract. Berlin: Springer-Verlag, 1987.
49. Turner-Warwick R. Observations on the function and dysfunction of the sphincter and detrusor mechanisms. Urol Clin North Am 1979; 6: 23-29.
50. Van Arsdalen K, Wein AJ. Physiology of micturition and continence. In: Krane RD, Siroky M, eds. Clinical neuro-urology. New York: Little Brown, 1991: 25-82.
51. Winkler HA, Sand PK. Treatment of detrusor instability with oxybutynin rectal suppositories. Int Urogynecol J 1998; 9: 100-102.